Cryo-Cell International
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
39.12
Price/Sales ratio
N/A
Earnings per Share (EPS)
$0.12

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
51.463.88-26.1024.58-63.9027.7216.8448.3513.34-4.68-6.97-63.90
Price/Sales ratio
1.411.491.492.241.861.991.963.481.211.421.951.86
Price/Book Value ratio
-2.65-6.34-2.23-4.55-6.13-9.13-22.9024.07-24.26-4.04-6.51-9.13
Price/Cash Flow ratio
18.326.486.919.9510.2410.047.2112.704.315.008.6410.04
Price/Free Cash Flow ratio
19.866.637.4210.1211.6511.217.61103.33-4.3034.8435.4711.65
Price/Earnings Growth ratio
0.020.000.21-0.080.47-0.070.25-1.050.490.01-1.81-0.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A20.74%N/A3.23%N/A
Profitability Indicator Ratios
Gross Profit Margin
72.01%73.30%75.03%73.50%70.77%68.45%68.99%68.87%71.01%73.06%73.65%70.77%
Operating Profit Margin
9.84%13.90%1.87%19.72%17.76%15.91%24.59%13.85%13.26%-39.25%-39.49%15.91%
Pretax Profit Margin
3.36%4.50%-10.72%14.27%12.38%10.65%16.17%9.04%10.94%-42.63%-38.77%10.65%
Net Profit Margin
2.75%38.43%-5.71%9.12%-2.92%7.19%11.63%7.21%9.13%-30.37%-28.03%7.19%
Effective Tax Rate
18.24%-753.72%46.74%36.11%123.62%32.45%28.07%20.20%16.49%28.75%27.70%32.45%
Return on Assets
5.42%41.57%-6.76%9.68%-2.01%5.34%7.84%3.43%4.27%-15.55%-14.18%5.34%
Return On Equity
-5.16%-163.29%8.56%-18.51%9.59%-32.94%-136.00%49.79%-181.81%86.31%85.68%9.59%
Return on Capital Employed
183.03%32.32%6.74%50.21%19.24%18.43%25.72%10.11%8.86%-30.48%-27.62%18.43%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.61N/A
Quick Ratio
0.830.940.650.890.870.921.070.700.440.410.560.92
Cash ratio
0.350.390.260.450.390.420.630.390.080.010.010.42
Days of Sales Outstanding
73.8452.9263.9573.7073.2969.9474.0966.3872.7176.5878.8073.29
Days of Inventory outstanding
59.2930.8222.8217.07685.4039.4435.0437.4035.3333.2431.8239.44
Operating Cycle
133.1383.7586.7890.77758.69109.39109.14103.78108.05109.82110.63110.63
Days of Payables Outstanding
64.3486.1293.88104.6853.9249.7936.1860.4866.64137.2587.0653.92
Cash Conversion Cycle
68.79-2.36-7.10-13.90704.7759.5972.9543.2941.41-27.4223.5659.59
Debt Ratios
Debt Ratio
N/A0.06N/AN/AN/A0.070.120.030.160.160.170.17
Debt Equity Ratio
N/A-0.23N/AN/AN/A-0.44-2.220.45-7.21-0.89-1.12-0.44
Long-term Debt to Capitalization
N/A-0.21N/AN/AN/AN/A16.13N/A1.21-3.24-6.78N/A
Total Debt to Capitalization
N/A-0.31N/AN/AN/A-0.801.810.311.16-8.099.179.17
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-11.23N/A
Cash Flow to Debt Ratio
N/A4.12N/AN/AN/A2.031.424.170.770.900.672.03
Company Equity Multiplier
-0.95-3.92-1.26-1.91-4.75-6.16-17.3314.49-42.56-5.54-6.58-6.16
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.070.230.210.220.180.190.270.270.280.280.220.18
Free Cash Flow / Operating Cash Flow Ratio
0.920.970.930.980.870.890.940.12-1.000.140.240.89
Cash Flow Coverage Ratio
N/A4.12N/AN/AN/A2.031.424.170.770.900.672.03
Short Term Coverage Ratio
N/A15.78N/AN/AN/A2.032.734.173.536.423.002.03
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A276.85%N/AN/AN/A